Teleflex (NYSE: TFX) didn't hit the Street's expectations last quarter, but investors hope that it will rebound this quarter. The company will unveil its latest earnings Wednesday. Teleflex is a global provider of medical technology products that enable health-care providers to improve patient outcomes, reduce infections, and enhance patient and provider safety.

What analysts say:

  • Buy, sell, or hold?: Analysts think investors should stand pat on Teleflex, with four of six analysts rating it hold. Analysts don't like Teleflex as much as competitor Cooper Companies overall. Five out of eight analysts rate Cooper Companies a buy compared with two of six for Teleflex. Analysts haven't adjusted their rating of Teleflex for the past three months.
  • Revenue forecasts: On average, analysts predict $370.6 million in revenue this quarter. That would represent a decline of 18.8% from the year-ago quarter.
  • Wall Street earnings expectations: The average analyst estimate is earnings of $0.95 per share. Estimates range from $0.90 to $1.09.

What our community says:
CAPS All-Stars are solidly behind the stock, with 93.3% awarding it an "outperform" rating. The community at large concurs with the All-Stars, with 92.5% granting it a rating of "outperform." Fools are keen on Teleflex, though the message boards have been quiet lately with only 33 posts in the past 30 days. Even with a robust four out of five stars, Teleflex's CAPS rating falls a little short of the community's upbeat outlook.

Teleflex's profit has risen year over year by an average of more than threefold. Revenue has fallen for the past three quarters.

Now let's look at how efficient management is at running the business. Traditionally, margins represent the efficiency with which companies capture portions of sales dollars. The following table shows gross, operating, and net margins over the past four quarters.






Gross Margin





Operating Margin





Net Margin





For all our Teleflex-specific analysis, including earnings and beyond, add Teleflex to My Watchlist.

Motley Fool newsletter services have recommended buying shares of Teleflex. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.